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The Wellcome Witnesses to Twentieth
Century Medicine Seminars bring together clini-
cians, scientists, historians and others interested
in contemporary medical history who were asso-
ciated with a particular set of circumstances or
events. Participants come together to discuss,
debate, and agree or disagree about their memo-
ries. The seminars are recorded, the tapes are
transcribed and the unedited transcript is imme-
diately sent to each participant, to check their
own contributions and provide brief biographical
details. The editors from the Wellcome Trust
Centre for the History of Medicine at UCL (1)
then turn the transcript into readable text. The
purpose of these seminars is to promote interac-
tion between these different groups, to
emphasise the potential benefits of working
jointly, and to encourage the creation and deposit
of archival sources for present and future use.
This seminar on platinum salts, as they are
described here (although this term may not be to
the ‘taste’ of coordination chemists), describes
the events surrounding a revolution in cancer
chemotherapy. The topic is ideally suited to the
Wellcome Witness Seminar series. 
It is well known that Barnett Rosenberg and
his coworkers at Michigan State University,
U.S.A., are responsible for the discovery of 
the anticancer properties of cisplatin (2). In this
book we hear of the nascent events that
occurred, the people involved and their contri-
bution, although unfortunately Rosenberg
himself sent his apologies and did not participate
in the discussion. In my view what is most fasci-
nating about this transcript is the link between
Rosenberg’s fundamental experiments and the
notion of a practical anticancer drug – and one
based on platinum! The work of Rosenberg is
frequently quoted, including the following state-
ment: “I just thought, by intuition, I might try it”
(3). It would be interesting to know how many
people owe their lives to this throwaway com-
ment; it must be hundreds of thousands, if not
millions. We then learn about the subsequent
clinical development of cisplatin, the dedication,
determination and belief that was required to
prove the utility of this compound. 
In many ways the book is thought provoking –
in today’s culture of drug development, it is
almost impossible to imagine how a maverick
compound, which cisplatin was, could ever be
developed, or how a modern equivalent to
Rosenberg would be funded to do medical
research. Dialogue between chemists in academia
and medical doctors is probably at an all time 
low – everyone is too busy to talk to each other –
and the legislation and costs associated with 
clinical trials prevent many putative compounds
from being adequately evaluated. It is these cul-
tural differences that make this book particularly
interesting to me. It raises many questions: could
such an amazing discovery happen today; can
funding agencies provide an atmosphere to allow
such processes to occur, or is it due to one or
two truly brilliant scientists who are not afraid to
go beyond their own areas of expertise? From
Platinum Metals Rev., 2009, 53, (1), 35–36 35
“The Discovery, Use and Impact of
Platinum Salts as Chemotherapy Agents
for Cancer”
WELLCOME WITNESSES TO TWENTIETH CENTURY MEDICINE, Volume 30
EDITED BY D. A. CHRISTIE and E. M. TANSEY, The Wellcome Trust Centre for the History of Medicine at UCL, London, U.K., 2007,
117 pages, ISBN 978-085484-112-7, £6.00 (Print version), Free of charge (Online version)
Reviewed by Paul J. Dyson
Swiss Federal Institute of Technology, EPFL, ISIC-LCOM-BCH, Lausanne, CH-1015, Switzerland; E-mail: paul.dyson@epfl.ch 
DOI: 10.1595/147106709X396980
this book, we can certainly learn a great deal
about the conditions required to develop a revo-
lutionary anticancer drug, but I have my doubts
whether these conditions could easily be emulat-
ed today. The process of discovering new drugs
will only become increasingly difficult with time.
Even though the book is a little repetitive at
times, it was enjoyable to read and enlightening
in many ways. The entire text is available 
to download as a PDF file, free of charge, 
from the Wellcome Trust Centre website (3).
Alternatively, a nicely bound paper copy can be
purchased for £6.00. I doubt that this book
would be a priority purchase for many chemistry
or medical libraries in academia or industry, but I
am pleased to have been asked to review this
book as it is unlikely that I would have otherwise
discovered it. 
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The Wellcome Witness Seminar 
The book is the transcript of a Witness Seminar held by the Wellcome Trust Centre for the
History of Medicine at UCL, London, U.K., on 4th April 2006.
Participants included: Professor Paul Andrews, Professor Kenneth Bagshawe, Dr Penelope
Brock, Professor Sir Kenneth Calman, Professor Hilary Calvert, Professor David Grahame-Smith,
Professor Richard Gralla, Professor Kenneth Harrap, Dr James Hoeschele, Professor Ian Judson,
Mr Wesley Miner, Professor Robert Naylor, Mrs Brenda Reynolds, Dr John Rudd, Dr Gareth
Sanger, Dr Tilli Tansey, Dr David Tattersall, Professor Andrew Thomson, Professor Robert
Williams, Dr Eve Wiltshaw. 
Among those attending the meeting were: Dr Jeffrey Aronson, Dr Chris Barnard, Dr Barry
Murrer, Dr Mark Walport, Mrs Julie Wenn, Dr Lise Wilkinson, Dr Tony Woods.
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